Review: taking Pantoprazole sodium and Rosuvastatin calcium together


Summary

Drug interactions are reported among people who take Pantoprazole sodium and Rosuvastatin calcium together. This review analyzes the effectiveness and drug interactions between Pantoprazole sodium and Rosuvastatin calcium. It is created by eHealthMe based on reports of 1,973 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Pantoprazole sodium and Rosuvastatin calcium >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Pantoprazole Sodium

Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastrooesophageal reflux disease. (latest outcomes from Pantoprazole sodium 12,646 users)

Rosuvastatin Calcium

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in hyperlipidaemia. (latest outcomes from Rosuvastatin calcium 1,402 users)

On Jul, 23, 2016

1,973 people who take Pantoprazole Sodium, Rosuvastatin Calcium are studied.


Number of reports submitted per year:

Pantoprazole sodium and Rosuvastatin calcium drug interactions.

Drug effectiveness over time:

Pantoprazole Sodium:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 80.0% - (8 of 10 people)
  • 6 - 12 months: 28.0% - (2 of 7 people)
  • 1 - 2 years: 42.0% - (6 of 14 people)
  • 2 - 5 years: 74.0% - (26 of 35 people)
  • 5 - 10 years: 64.0% - (9 of 14 people)
  • 10+ years: 88.0% - (8 of 9 people)
  • not specified: 100.0% - (1 of 1 people)
Rosuvastatin Calcium:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 40.0% - (4 of 10 people)
  • 6 - 12 months: 25.0% - (2 of 8 people)
  • 1 - 2 years: 62.0% - (10 of 16 people)
  • 2 - 5 years: 60.0% - (18 of 30 people)
  • 5 - 10 years: 53.0% - (8 of 15 people)
  • 10+ years: 20.0% - (1 of 5 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Pantoprazole Sodium:
  • female: 66.0% - (35 of 53 people)
  • male: 64.0% - (25 of 39 people)
Rosuvastatin Calcium:
  • female: 44.0% - (22 of 50 people)
  • male: 61.0% - (22 of 36 people)

Drug effectiveness by age:

Pantoprazole Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (3 of 3 people)
  • 40-49: 33.0% - (3 of 9 people)
  • 50-59: 58.0% - (20 of 34 people)
  • 60+: 73.0% - (34 of 46 people)
Rosuvastatin Calcium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (2 of 2 people)
  • 40-49: 50.0% - (3 of 6 people)
  • 50-59: 43.0% - (14 of 32 people)
  • 60+: 54.0% - (25 of 46 people)

Most common drug interactions over time *:

< 1 month:
  • febrile neutropenia
  • pneumonia
  • asthenia
  • neutropenia
  • rhabdomyolysis
  • fatigue
  • productive cough
  • atrial fibrillation
  • blood creatinine increased
  • dizziness
1 - 6 months:
  • myalgia
  • convulsion
  • nausea
  • rhabdomyolysis
  • weight decreased
  • asthenia
  • back pain
  • blood creatinine increased
  • chest pain
  • dizziness
6 - 12 months:
  • bone density decreased
  • carpal tunnel syndrome
  • osteoporosis
  • spinal compression fracture
  • spinal fracture
  • cubital tunnel syndrome
  • epicondylitis
  • ligament sprain
  • burning feet syndrome
  • muscle rupture
1 - 2 years:
  • myalgia
  • abdominal pain aggravated
  • pancreatitis
  • peripheral neuropathy
  • weight gain
  • agitation
  • alopecia
  • amnesia
  • anxiety
  • bone density decreased
2 - 5 years:
  • night sweats
  • acid reflux
  • cholesterol test
  • high blood pressure
  • shortness of breath
  • tendonitis
  • serotonin syndrome
  • abdominal pain aggravated
  • axonal neuropathy
  • blood creatine phosphokinase increased
5 - 10 years:
  • hyperhidrosis
  • male sexual dysfunction
  • myalgia
  • anorgasmia
  • anxiety
  • chest pain
  • delayed ejaculation
  • dry mouth
  • hearing loss
  • sexual dysfunction
10+ years:
  • erectile dysfunction
  • impotence
  • arthritis
  • bone and joint pain
  • breast lump
  • coma
  • gums - swollen
  • hot flushes aggravated
  • muscle cramps
  • muscle spasms
not specified:
  • dyspnoea
  • nausea
  • pain
  • dizziness
  • anxiety
  • fatigue
  • asthenia
  • depression
  • pneumonia
  • vomiting

Most common drug interactions by gender *:

female:
  • dyspnoea
  • pain
  • nausea
  • anxiety
  • asthenia
  • fatigue
  • dizziness
  • depression
  • arthralgia
  • gastrooesophageal reflux disease
male:
  • nausea
  • dyspnoea
  • pain
  • dizziness
  • myocardial infarction
  • atrial fibrillation
  • vomiting
  • anxiety
  • pneumonia
  • cardiac failure congestive

Most common drug interactions by age *:

0-1:
  • atrioventricular block complete
  • atrioventricular block second degree
  • hepatic pain
  • hepatitis
  • hepatomegaly
10-19:
  • abdominal pain upper
  • anxiety
  • chest pain
  • dyspnoea
  • emotional distress
  • general physical health deterioration
  • injury
  • mental disorder
  • pain
  • palpitations
20-29:
  • asthma
  • cholecystitis chronic
  • diabetes mellitus
  • diabetes mellitus inadequate control
  • impaired gastric emptying
  • pancreatitis
  • pancreatitis acute
  • syncope
30-39:
  • anxiety
  • convulsion
  • dyskinesia
  • dysphagia
  • fatigue
  • injury
  • pain
  • type 2 diabetes mellitus
  • anhedonia
  • asthenia
40-49:
  • diabetes mellitus
  • weight increased
  • arthralgia
  • diarrhoea
  • anxiety
  • dizziness
  • pain
  • cellulitis
  • pneumonia
  • nausea
50-59:
  • nausea
  • vomiting
  • dyspnoea
  • pain
  • diarrhoea
  • myocardial infarction
  • hypertension
  • dizziness
  • pyrexia
  • anxiety
60+:
  • dyspnoea
  • nausea
  • asthenia
  • atrial fibrillation
  • dizziness
  • pneumonia
  • fatigue
  • pain
  • anaemia
  • anxiety

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Pantoprazole sodium and Rosuvastatin calcium?

Can you answer these questions?

More questions for: Pantoprazole sodium, Rosuvastatin calcium

You may be interested in these reviews

More reviews for: Pantoprazole sodium, Rosuvastatin calcium

On eHealthMe, Pantoprazole sodium (pantoprazole sodium) is often used to treat gastrooesophageal reflux disease. Rosuvastatin calcium (rosuvastatin calcium) is often used to treat hyperlipidaemia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.